Chronic Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System [Phase 3]
Phase 3 trial update on discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia and its impact on the immune system.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System [Phase 3]
Phase 3 trial update regarding discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia and its effects on the immune syste…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Natural Killer Cells and Bortezomib to Treat Cancer [Phase 1]
This Phase 1 clinical trial update reports on the combination of natural killer cells and bortezomib for several cancers, and the study has …
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors [Phase 1, Phase 2]
The document reports ongoing Phase 1/2 clinical trials evaluating ponatinib in pediatric patients with recurrent or refractory leukemias, ly…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial update. It evaluates a conditioning strategy using chemotherapy, total body irradiation, and post-transpl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia [Phase 2]
Phase 2 clinical trial update evaluating whether stopping tyrosine kinase inhibitors can influence treatment-free remission in patients with…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT [Phase 1]
Phase 1 clinical trial update on DLI-X as a prophylactic and therapeutic donor lymphocyte infusion to prevent or treat leukemia relapse afte…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Study of Full Treatment-free Remission in Patients With Chronic Myeloid Leukemia [Phase 2]
Phase 2 study in chronic myeloid leukemia evaluating full treatment-free remission has completed and results are reported.
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial update evaluating TCRαβ-depleted progenitor cell graft with added memory T-cell donor lymphocyte infusion and selecti…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) [Phase 3]
Phase 3 trial comparing Asciminib to Nilotinib in adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in c…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: Treatment Patterns and Key Endpoints Among Patients With Chronic-Phase Chronic Myeloid Leukemia in a Community Oncology Setting
A completed clinical trial update analyzing treatment patterns and key endpoints for patients with chronic-phase chronic myeloid leukemia in…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia [Phase 2]
Phase 2 trial of dasatinib in patients with early chronic phase chronic myeloid leukemia has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: ABL001 for the Treatment of Chronic Myeloid Leukemia in Patients Who Are on Therapy With Tyrosine Kinase Inhibitor [Phase 2]
A Phase 2 trial of ABL001 (asciminib) for chronic myeloid leukemia patients on tyrosine kinase inhibitors was terminated, and results have b…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Off-the-shelf NK Cells + SCT for Myeloid Malignancies [Phase 2]
Phase 2 trial evaluating off-the-shelf natural killer (NK) cells in combination with stem cell transplantation for myeloid malignancies has …
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia [Phase 2]
A Phase 2 trial is evaluating the addition of ruxolitinib to standard tyrosine kinase inhibitor therapy for chronic myeloid leukemia in chro…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer [Phase 1]
A Phase 1 trial evaluating natural killer cell therapy in combination with Interleukin-2 and the TGF-beta receptor I inhibitor vactosertib f…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine [Phase 1]
A Phase 1 clinical trial evaluating a haploidentical bone marrow transplant using post-transplant cyclophosphamide and bendamustine has comp…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg [Phase 1]
Phase 1 dose-calibration study comparing IkT-001Pro to imatinib 400 mg in chronic myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL [Phase 1]
HQP1351 is being investigated in a Phase 1 trial for patients with refractory chronic myeloid leukemia and Philadelphia chromosome-positive …
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion [NA]
Clinical trial update from Baylor College of Medicine reports results for haploidentical hematopoietic cell transplantation using TCR alpha/…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patients [Phase 3]
A Phase 3 trial evaluating nilotinib with or without pegylated interferon as first-line therapy for chronic-phase chronic myeloid leukemia h…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment
A completed clinical trial reported on treatment patterns and outcomes for chronic myeloid leukemia across all lines of therapy.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: TGRX-678 Pharmacokinetic Mass Balance [Phase 1]
Phase 1 pharmacokinetic mass balance study of TGRX-678 has been completed, summarizing absorption, distribution, metabolism, and excretion c…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients
A real-world study evaluating how adverse events influence treatment changes, healthcare resource use, and costs in chronic myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: A Bioavailability Study of Nilotinib in Healthy, Adult, Human Subjects Under Fasted Conditions. [Phase 1]
A Phase 1 bioavailability study of nilotinib in healthy adult participants under fasted conditions has been completed.